Harrow Health market cap is $138.9 m, and annual revenue was $41.37 m in FY 2018

Harrow Health Gross profit (Q2, 2019)8.3 M

Harrow Health Gross profit margin (Q2, 2019), %61.3%

Harrow Health EBIT (Q2, 2019)-767 K

USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
---|---|---|---|---|---|---|

## Revenue | 1.7m | 9.7m | 19.9m | 26.8m | 41.4m | |

| 485% | 105% | ||||

## Cost of goods sold | 1.1m | 5.2m | 9.8m | 13.5m | 16.5m | |

## Gross profit | 567.4k | 4.5m | 10.1m | 13.3m | 24.9m | |

| 34% | 46% | 51% | 50% | 60% | |

## Sales and marketing expense | 6.5m | 7.4m | 7.1m | |||

## R&D expense | 1.6m | 332.0k | 739.0k | 413.0k | 825.0k | |

## General and administrative expense | 6.1m | 12.5m | 17.6m | 18.0m | 29.2m | |

## Operating expense total | 7.7m | 19.3m | 26.0m | 25.4m | 30.1m | |

## EBIT | (7.7m) | (10.1m) | (14.8m) | (15.9m) | (12.2m) | (5.2m) |

| (611%) | (153%) | (80%) | (45%) | (13%) | |

## Interest expense | 3.8k | 1.1m | 2.8m | 3.0m | 2.7m | |

## Interest income | 43.8k | 32.4k | 1.1m | |||

## Pre tax profit | (12.9m) | 14.6m | ||||

## Income tax expense | 111.0k | 935.0k | ||||

## Net Income | (7.6m) | (10.1m) | (15.9m) | (19.1m) | (12.0m) | 14.6m |

USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
---|---|---|---|---|---|---|

## Cash | 15.6m | 8.2m | 2.7m | 8.9m | 4.0m | |

## Accounts Receivable | 81.3k | 840.0k | 2.9m | 1.5m | 1.9m | |

## Inventories | 105.1k | 372.7k | 1.4m | 1.8m | 2.2m | 1.8m |

## Current Assets | 15.7m | 9.1m | 5.9m | 14.8m | 8.8m | 32.8m |

## PP&E | 7.3m | 6.2m | 6.4m | |||

## Goodwill | 331.6k | 2.5m | 2.2m | 2.2m | 2.2m | |

## Total Assets | 15.8m | 10.2m | 14.1m | 27.2m | 23.9m | 49.5m |

## Accounts Payable | 311.9k | 786.7k | 3.4m | 3.5m | 3.9m | 6.3m |

## Short-term debt | 24.1k | 21.0k | ||||

## Current Liabilities | 650.6k | 1.6m | 5.4m | 9.9m | 5.8m | 11.9m |

## Long-term debt | ||||||

## Total Debt | 21.0k | |||||

## Total Liabilities | 15.5m | 20.8m | 21.3m | 24.7m | ||

## Additional Paid-in Capital | 46.8m | 50.0m | 56.4m | 83.3m | 91.4m | 98.9m |

## Retained Earnings | (41.9m) | (57.8m) | (76.9m) | (88.8m) | (74.2m) | |

## Total Equity | 15.1m | 8.2m | (1.4m) | 6.4m | 2.6m | 24.8m |

## Financial Leverage | 1 x | 1.3 x | -10.2 x | 4.2 x | 9.1 x | 2 x |

USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
---|---|---|---|---|---|---|

## Net Income | (7.6m) | (10.1m) | (15.9m) | (19.1m) | (12.0m) | 14.6m |

## Depreciation and Amortization | 5.7k | |||||

## Accounts Receivable | (22.9k) | (360.0k) | (2.1m) | 1.4m | (384.0k) | |

## Inventories | (17.0k) | (159.5k) | (314.0k) | (429.0k) | (821.0k) | 415.0k |

## Accounts Payable | (239.8k) | 345.4k | 1.0m | 1.5m | 346.0k | 2.4m |

## Cash From Operating Activities | (4.4m) | (7.1m) | (11.1m) | (11.2m) | (8.8m) | 687.0k |

## Purchases of PP&E | (6.9m) | (772.0k) | (1.8m) | |||

## Cash From Investing Activities | (70.0k) | (910.5k) | (5.1m) | (7.3m) | (961.0k) | (2.2m) |

## Cash From Financing Activities | 10.1m | 598.1k | 10.7m | 24.7m | 4.9m | 4.1m |

## Interest Paid | 3.8k | 637.0k | 1.4m | 1.5m | 2.1m | |

## Income Taxes Paid | 1.6k | 800.0 | 1.0k | 9.0k | 9.0k | 4.0k |

USD | Y, 2019 |
---|---|

## Financial Leverage | 1.9 x |